• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地昔帕明及其他抗抑郁药物对神经递质受体的调节:抗抑郁作用的神经递质受体假说

Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.

作者信息

Stahl S M

出版信息

J Clin Psychiatry. 1984 Oct;45(10 Pt 2):37-45.

PMID:6090439
Abstract

Recent findings on neurotransmitter receptors are reviewed as they relate to current hypotheses of the etiology of depression and mechanism of action of antidepressant drugs. Two important research areas are 1) the finding that each synapse may have more than one neurotransmitter, and 2) data which link specific neurotransmitters and receptors to depressive illness and antidepressant drug response. A new hypothesis that has emerged from receptor studies is the neurotransmitter receptor hypothesis of antidepressant reaction, which states that antidepressants exert their effects by down-regulating neurotransmitter receptors. Research questions generated by these hypotheses are reviewed, and implications of findings in this area for the development of more effective, rapid-acting antidepressants are discussed.

摘要

本文综述了神经递质受体的最新研究成果,这些成果与当前关于抑郁症病因和抗抑郁药物作用机制的假说相关。两个重要的研究领域是:1)发现每个突触可能不止有一种神经递质;2)将特定神经递质和受体与抑郁症及抗抑郁药物反应联系起来的数据。受体研究中出现的一个新假说是抗抑郁反应的神经递质受体假说,该假说认为抗抑郁药通过下调神经递质受体发挥作用。本文对这些假说引发的研究问题进行了综述,并讨论了该领域研究结果对开发更有效、起效更快的抗抑郁药物的意义。

相似文献

1
Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.地昔帕明及其他抗抑郁药物对神经递质受体的调节:抗抑郁作用的神经递质受体假说
J Clin Psychiatry. 1984 Oct;45(10 Pt 2):37-45.
2
Biological basis of depression and therapeutic relevance.抑郁症的生物学基础及治疗相关性。
J Clin Psychiatry. 1991 Jun;52 Suppl:4-10.
3
Molecular and cellular mechanisms of antidepressant drugs.抗抑郁药物的分子和细胞机制
Depress Anxiety. 1996;4(4):153-9. doi: 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G.
4
Receptor alterations associated with serotonergic agents: an autoradiographic analysis.与血清素能药物相关的受体改变:放射自显影分析
J Clin Psychiatry. 1987 Mar;48 Suppl:19-25.
5
[Antidepressant drugs and central monoaminergic receptors].[抗抑郁药物与中枢单胺能受体]
Yakubutsu Seishin Kodo. 1985 Dec;5(4):303-19.
6
[Mechanism of action of antidepressants and therapeutic perspectives].[抗抑郁药的作用机制及治疗前景]
Therapie. 2002 Jul-Aug;57(4):385-96.
7
Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.关于血清素在抗抑郁药物作用机制中的作用的临床数据。
J Clin Psychiatry. 1990 Apr;51 Suppl:44-50; discussion 51-2.
8
5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?5-羟色胺1A受体与药物治疗。血清素受体下调与抗抑郁药物的作用机制有关吗?
Psychopharmacol Bull. 1994;30(1):39-43.
9
[Status of amine hypotheses in depressive disorders].[胺假说在抑郁症中的现状]
Nervenarzt. 1992 Jan;63(1):3-13.
10
Models of antidepressant action.抗抑郁作用模型。
J Clin Psychiatry. 1999;60 Suppl 14:16-20; discussion 31-5.

引用本文的文献

1
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression.综述内源性大麻素系统在抑郁症病理生理学中的作用。
Front Pharmacol. 2021 Dec 6;12:762738. doi: 10.3389/fphar.2021.762738. eCollection 2021.
2
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder.从血清素到神经可塑性:重度抑郁症理论的演变
Front Cell Neurosci. 2017 Sep 28;11:305. doi: 10.3389/fncel.2017.00305. eCollection 2017.
3
Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.
10-N-取代吖啶酮作为恶性疟原虫新型化学增敏剂的设计、合成与评价
Antimicrob Agents Chemother. 2007 Nov;51(11):4133-40. doi: 10.1128/AAC.00669-07. Epub 2007 Sep 10.